Our results revealed a significant increase in anti-trimeric SOD1 antibodies in ALS patients compared to healthy controls (p = 0.001), while responses to dimeric and fibrillar SOD1 showed no significant differences between groups (Fig. 1). The gene discussed is SOD1; the disease is amyotrophic lateral sclerosis.